Interestingly, we found that elevated EGFR activity scores were significantly associated with the poor overall survival of cisplatin-treated cervical cancer patients, but not cisplatin-untreated cervical cancer patients (Fig. 1a), suggesting hyperactivated EGFR signaling might be a crucial candidate that induces cisplatin resistance. Here, EGFR is linked to cervical carcinoma.